HESTERBIONSEHester Biosciences LimitedLowNeutral
Announced Fri, 11 Jul · 13:27 IST

Hester Biosciences Limited has informed the Exchange regarding Notice of 38th Annual General Meeting to be held on Wednesday, 13 August 2025

Board & Shareholder Meetings View source PDF

HESTERBIO · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Hester Biosciences has notified the exchanges about its 38th Annual General Meeting scheduled for Wednesday, 13 August 2025 at 10:30 a.m. IST, to be held via Video Conference. Shareholders of record as of 6 August 2025 will be eligible for the final dividend and e-voting, with e-voting open from 10 August (9:00 a.m.) to 12 August (5:00 p.m.); dividend payment is set for on or after 19 August 2025. The accompanying Annual Report shows standalone revenue from operations of INR 2,864.66 million (up 2% YoY) and standalone PAT of INR 318.42 million (up 17% YoY). On a consolidated basis, revenue stood at INR 3,111.02 million with PAT of INR 288.26 million (up 36% YoY), reflecting improved operational efficiency. The Board has recommended a final dividend of INR 7 per share (face value INR 10), higher than the INR 6 paid in FY24.

Likely market impact

Shareholders should note the 6 August 2025 record date to be eligible for the higher dividend and to participate in e-voting. Stronger consolidated profit growth and a higher dividend payout signal improved profitability, which may be viewed positively by investors.